Core Points - Geely Automobile announced the issuance of 30,500 ordinary shares on October 17, 2025, due to employees exercising stock options under a plan adopted on April 28, 2023 [1] - An additional 10,000 ordinary shares will be issued on the same date due to related entity participants exercising stock options under the same plan [1]

Core Viewpoint - Geely Automobile (00175) announced the issuance of 4,000 ordinary shares on October 8, 2025, due to employees exercising stock options under a plan adopted on April 28, 2023 [1] Summary by Relevant Sections - **Company Announcement** - Geely Automobile will issue 4,000 ordinary shares as a result of employees exercising stock options [1]

Core Viewpoint - Geely Automobile (00175) announced the issuance of 33,400 ordinary shares on October 3, 2025, due to employees exercising stock options under a plan adopted on April 28, 2023 [1] Group 1 - The stock option plan was adopted on April 28, 2023 [1] - The total number of ordinary shares to be issued is 33,400 [1]

Core Points - Geely Automobile (00175) announced the issuance of 30,000 ordinary shares on September 15, 2025, due to employees exercising stock options under a plan adopted on April 28, 2023 [1] Company Summary - The stock option plan was approved on April 28, 2023, indicating the company's strategy to incentivize employees through equity participation [1] - The issuance of shares is part of the company's broader employee compensation strategy, which may impact shareholder value and equity structure [1]

Group 1 - The core point of the article highlights that on August 21, shareholders of China Silver Technology (00515) transferred shares from Shenwan Hongyuan Securities (000562) Hong Kong to Hang Seng Securities, with a transfer market value of HKD 6.8462 million, accounting for 5.85% of the total shares [1] - China Silver Technology announced that on June 10, 2025, it will issue 134 million ordinary shares based on a conversion price of HKD 0.114 per share, in exchange for a total principal amount of HKD 15.2623 million of convertible bonds [1]

Core Viewpoint - Green Leaf Pharmaceutical (02186) announced the issuance of 21,167,800 ordinary shares by converting $10 million of 5.85% convertible bonds due in 2025 at an exchange price of HKD 3.672 per share [1] Group 1 - The company is converting $10 million of its 5.85% convertible bonds into ordinary shares [1] - The conversion price is set at HKD 3.672 per share [1] - A total of 21,167,800 ordinary shares will be issued as a result of this conversion [1]